• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treating older adults with schizophrenia: challenges and opportunities.治疗老年精神分裂症患者:挑战与机遇。
Schizophr Bull. 2013 Sep;39(5):966-8. doi: 10.1093/schbul/sbt043. Epub 2013 Apr 3.
2
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
3
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.
4
TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.抗精神病药物在新诊断的精神分裂症或持续性妄想障碍且精神病症状缓解患者中的减量停药与维持治疗对比研究:一项随机临床试验的研究方案
Trials. 2017 Sep 29;18(1):445. doi: 10.1186/s13063-017-2172-4.
5
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
6
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.专家共识指南系列。优化精神障碍的药物治疗。引言:方法、评论与总结。
J Clin Psychiatry. 2003;64 Suppl 12:5-19.
7
Antipsychotic treatment for late-life schizophrenia.老年精神分裂症的抗精神病药物治疗。
Curr Psychiatry Rep. 2002 Aug;4(4):299-306. doi: 10.1007/s11920-996-0050-y.
8
Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome.长效非典型抗精神病药治疗精神分裂症:对功能结局影响的系统评价和荟萃分析。
Aust N Z J Psychiatry. 2019 Jun;53(6):509-527. doi: 10.1177/0004867419837358. Epub 2019 Apr 8.
9
Long-acting injectable antipsychotics in the elderly: guidelines for effective use.老年患者长效注射用抗精神病药物:有效使用指南
Drugs Aging. 2003;20(15):1099-110. doi: 10.2165/00002512-200320150-00003.
10
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review.最低或不使用抗精神病药物的精神分裂症或精神病患者的心理社会干预:系统评价。
Schizophr Res. 2020 Nov;225:15-30. doi: 10.1016/j.schres.2019.05.020. Epub 2019 May 21.

引用本文的文献

1
Psychosocial Interventions Impact on Cardiometabolic, Neurobiological, Behavioral, and Immune Outcomes in People With a Serious Mental Illness: A Systematic Review.心理社会干预对严重精神疾病患者心脏代谢、神经生物学、行为及免疫结局的影响:一项系统综述
Health Sci Rep. 2025 Jul 21;8(7):e70954. doi: 10.1002/hsr2.70954. eCollection 2025 Jul.
2
Longitudinal trends in schizophrenia among older adults: a 12-year analysis of prevalence and healthcare utilization in South Korea.韩国老年人精神分裂症的纵向趋势:一项关于患病率和医疗保健利用情况的12年分析。
Schizophrenia (Heidelb). 2025 Feb 27;11(1):30. doi: 10.1038/s41537-025-00575-4.
3
Utility of Digital Phenotyping Based on Wrist Wearables and Smartphones in Psychosis: Observational Study.基于手腕可穿戴设备和智能手机的数字表型分析在精神病中的效用:观察性研究
JMIR Mhealth Uhealth. 2025 Feb 5;13:e56185. doi: 10.2196/56185.
4
Physical health challenges faced by elders with severe mental illness: population-based retrospective cohort study.患有严重精神疾病的老年人面临的身体健康挑战:基于人群的回顾性队列研究。
BJPsych Open. 2024 Oct 15;10(6):e178. doi: 10.1192/bjo.2024.765.
5
Life Course Perspectives of Aging With Schizophrenia Spectrum Disorders in Psychiatric and Long-Term Care Facilities.精神科和长期护理机构中精神分裂症谱系障碍患者的老龄化的生命历程观点。
Gerontologist. 2024 May 1;64(5). doi: 10.1093/geront/gnad149.
6
Digital Phenotyping in Adults with Schizophrenia: A Narrative Review.精神分裂症成人的数字化表型:叙事综述。
Curr Psychiatry Rep. 2023 Nov;25(11):699-706. doi: 10.1007/s11920-023-01467-z. Epub 2023 Oct 20.
7
Predictors of admission to an assertive outreach service for psychosis in Lebanon.黎巴嫩针对精神病患者的积极外展服务的入院预测因素。
PLOS Glob Public Health. 2022 Dec 28;2(12):e0001428. doi: 10.1371/journal.pgph.0001428. eCollection 2022.
8
The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders.精神障碍新型治疗方法发现的艰难之路。
Adv Neurobiol. 2023;30:255-285. doi: 10.1007/978-3-031-21054-9_11.
9
Mortality in Schizophrenia-Spectrum Disorders: Recent Advances in Understanding and Management.精神分裂症谱系障碍中的死亡率:理解与管理的最新进展
Healthcare (Basel). 2022 Nov 25;10(12):2366. doi: 10.3390/healthcare10122366.
10
A Group Videogame-Based Physical Activity Program Improves Walking Speed in Older Adults Living With a Serious Mental Illness.一项基于电子游戏的团体体育活动计划可提高患有严重精神疾病的老年人的步行速度。
Innov Aging. 2022 Aug 11;6(6):igac049. doi: 10.1093/geroni/igac049. eCollection 2022.

本文引用的文献

1
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.40 岁以上患者使用均衡分层随机化比较 4 种非典型抗精神病药物的长期安全性和有效性:一项试验。
J Clin Psychiatry. 2013 Jan;74(1):10-8. doi: 10.4088/JCP.12m08001. Epub 2012 Nov 27.
2
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.精神分裂症患者在身体、认知和心理社会方面的老龄化轨迹不同。
Schizophr Bull. 2011 May;37(3):451-5. doi: 10.1093/schbul/sbr026.
3
Mobile interventions for severe mental illness: design and preliminary data from three approaches.针对严重精神疾病的移动干预措施:三种方法的设计与初步数据
J Nerv Ment Dis. 2010 Oct;198(10):715-21. doi: 10.1097/NMD.0b013e3181f49ea3.
4
Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness.随机试验:社会康复和综合医疗护理对患有严重精神疾病的老年人的影响。
J Consult Clin Psychol. 2010 Aug;78(4):561-73. doi: 10.1037/a0019629.
5
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).精神分裂症患者死亡率的11年随访:一项基于人群的队列研究(FIN11研究)
Lancet. 2009 Aug 22;374(9690):620-7. doi: 10.1016/S0140-6736(09)60742-X.
6
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms.老年患者对抗精神病药物运动副作用的敏感性:一项正电子发射断层扫描(PET)研究,探究潜在机制
Am J Geriatr Psychiatry. 2009 Mar;17(3):255-63. doi: 10.1097/JGP.0b013e318198776d.
7
Physical and mental health-related quality of life among older people with schizophrenia.老年精神分裂症患者与身心健康相关的生活质量
Schizophr Res. 2009 Mar;108(1-3):207-13. doi: 10.1016/j.schres.2008.12.008. Epub 2009 Jan 24.
8
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?精神分裂症死亡率的系统评价:不同死亡率差距是否随时间推移而恶化?
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31. doi: 10.1001/archpsyc.64.10.1123.
9
Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.针对老年精神分裂症患者的认知行为社交技能训练随机对照试验:12个月随访
J Clin Psychiatry. 2007 May;68(5):730-7. doi: 10.4088/jcp.v68n0510.
10
Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders.功能适应技能训练(FAST):一项针对中老年慢性精神障碍患者的社会心理干预随机试验。
Schizophr Res. 2006 Sep;86(1-3):291-9. doi: 10.1016/j.schres.2006.05.017. Epub 2006 Jun 30.

治疗老年精神分裂症患者:挑战与机遇。

Treating older adults with schizophrenia: challenges and opportunities.

机构信息

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.

出版信息

Schizophr Bull. 2013 Sep;39(5):966-8. doi: 10.1093/schbul/sbt043. Epub 2013 Apr 3.

DOI:10.1093/schbul/sbt043
PMID:23552180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3756792/
Abstract

Schizophrenia affects people of all age groups. Treatment plans for older adults with schizophrenia must consider the effects of age on the course of the illness as well as on the response to antipsychotics and to psychosocial interventions. Positive symptoms of schizophrenia tend to become less severe, substance abuse becomes less common, and mental health functioning often improves. Hospitalizations are more likely to be due to physical problems rather than psychotic relapses. Physical comorbidity is a rule, however, and older age is a risk factor for most side effects of antipsychotics, including metabolic syndrome and movement disorders. We recently reported high rates of adverse events and medication discontinuation along with limited effectiveness of commonly used atypical antipsychotics in older adults. Psychosocial interventions such as cognitive behavioral social skills training are efficacious in improving functioning in older adults with schizophrenia. In formulating treatment plans for this population, a balanced approach combining cautious antipsychotic medication use with psychosocial interventions is recommended. Antipsychotic medications should generally be used in lower doses in older adults. Close monitoring for side effects and effectiveness of the medications and a watchful eye on their risk:benefit ratio are critical. In a minority of patients it may be possible to discontinue medications. Sustained remission of schizophrenia after decades of illness is not rare, especially in persons who receive appropriate treatment and psychosocial support-there can be light at the end of a long tunnel.

摘要

精神分裂症影响所有年龄段的人。治疗老年精神分裂症患者的计划必须考虑年龄对疾病进程的影响,以及对抗精神病药物和心理社会干预的反应。精神分裂症的阳性症状往往会减轻,物质滥用变得不那么常见,心理健康功能通常会改善。住院往往是由于身体问题而不是精神病复发。然而,合并症是普遍存在的,并且随着年龄的增长,大多数抗精神病药物的副作用(包括代谢综合征和运动障碍)的风险因素也会增加。我们最近报告了在老年人群中,抗精神病药物不良反应和停药率较高,以及常用的非典型抗精神病药物疗效有限的情况。认知行为社会技能训练等心理社会干预措施在改善老年精神分裂症患者的功能方面是有效的。在为这一人群制定治疗计划时,建议采用一种平衡的方法,将谨慎使用抗精神病药物与心理社会干预相结合。在老年人群中,一般应使用较低剂量的抗精神病药物。密切监测药物的副作用和疗效,以及关注其风险效益比至关重要。在少数患者中,可能有可能停止药物治疗。经过几十年的疾病后,精神分裂症能持续缓解并不罕见,尤其是在接受适当治疗和心理社会支持的患者中——在漫长的隧道尽头,仍有一线光明。